Loading provider…
Loading provider…
Gastroenterology Physician in Birmingham, AL
NPI: 1457613580Primary Employer
University of Alabama Health Services Foundation, PC.
uabmedicine.org
HQ Phone
Get M.D. Meagan's Phone Numberphone_androidMobile
Get M.D. Meagan's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardAL State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 76 | 81 |
| 2 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 37 | 68 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 26 | 27 |
| 4 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 26 | 26 |
| 5 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 24 | 48 |
Obesity is a risk factor for progression to kidney transplant waitlisting after liver transplantation.
Authors: Elizabeth Pomfret, Kim Olthoff, Nancy Ascher, Babak Orandi, Deirdre Sawinski
Publication Date: 2021-01-17
Authors: Rohit Loomba, Mark Brantly, Igor Barjaktarevic, Ting Ting Chang, Brooks Kuhn, Paul Kwo, Antonio Sanchez, Virginia Clark, John Vierling, Monica Goldklang, Hugo Vargas
Journal: Gastroenterology
Publication Date: 2024-07-02
Web Exclusive. Annals On Call - Does Weight Loss Surgery Help Nonalcoholic Fatty Liver Disease?
Authors: Robert Centor
Journal: Ann Intern Med
Lead Sponsor: Galectin Therapeutics Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: belapectin
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Tirzepatide